Clinical Trial Update: BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial [Phase 2]

View source ↗

Summary

Phase II trial update for FOLFOX-A in metastatic pancreatic cancer by BrUOG 292; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FOLFOX-A

Snippet

Sponsor: Brown University | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-08-13